Nominations open for FDA Impact Award 2021

There is lots of fantastic work going on and our Impact Award is our way of recognising that work and saying thank you.
You can nominate a member, representative or branch who you think has made a difference in one (or more) of the following areas:
- Campaign: where a campaign has been run in a local area resulting in engaging members and/or a win on an issue.
- Engagement: members have been engaged to become more involved in the FDA, with high participation in branch structures/surveys or regular successful events.
- Branch development: introducing new forms of communication, recruiting members to the committee, increasing branch activity.
- Recruitment: where a large number of new members have been recruited, declining membership has been reversed, or where members have been recruited from unengaged areas or despite challenging circumstances.
- Casework: where a significant win has been achieved, a win on a difficult case or a win on a case that has resulted in wider change in the department.
- Negotiation: where a win has been achieved for members through negotiations with the employer.
To nominate an outstanding member, workplace rep or branch please complete this form and return by email to amy@fda.org.uk by midday Monday 12th April.
Related News
-

FDA responds to NICS decision not to participate in Belfast Pride 2026
The FDA’s National Officer for Northern Ireland Robert Murtagh has responded to the NICS decision not to take part in Belfast Pride 2026.
-

FDA welcomes launch of new Partnership Framework with the Cabinet Office
The FDA welcomes a new era in civil service employee relations with the launch of a new Partnership Framework with the Cabinet Office
-

FDA tells NICS inquiry – “you cannot separate the performance and culture of the civil service from the political and governance environment in which it operates”
The FDA’s National Officer for Northern Ireland Robert Murtaugh gave oral evidence to NI Assembly Finance Committee as part of their inquiry into the performance and culture of the NICS.